Abstract
BACKGROUND:
One of the leading causes of disability in the world with enormous economic burden is stroke.
OBJECTIVE:
To quantify the effectiveness of different protocols of cycling with/without functional electrical stimulation on functional mobility after stroke.
METHODS:
Multiple databases were searched till 2018. Data extraction was performed using a pre-determined data collection form. The quality of the evidence was evaluated using the Grading of Recommendations Assessment, Development and Evaluation.
RESULTS:
A total of 14 trials satisfied eligibility criteria and were included. Cycling had a positive effect on the 6-meter walking test performance (SMD, 0.41; 95% CI, 0.11 –0.71; I2 = 0% ) compared with no or placebo intervention (control). Compared with control, cycling had a positive effect on 10-meter walking speed (SMD, 0.30; 95% CI, 0.05 –0.55; I2 = 0% ), and on balance based on the Berg score (SMD, 0.32; 95% CI, 0.06 –0.57; I2 = 49% ). Cycling with functional electrical stimulation had a positive effect on balance (SMD, 1.48; 95% CI, 0.99 –1.97; I2 = 91% ) compared with cycling alone.
CONCLUSIONS:
It appears that cycling has a positive effect on walking speed, walking ability and balance. Functional electrical stimulation combined with cycling has positive effects on balance beyond cycling alone.
Introduction
One of the leading causes of disability in the world is stroke (Feigin et al., 2014; Lehmann et al., 2015). People who have sustained a stroke experience activity limitations such as a decreased ability to walk, and decreased participation in everyday life tasks (e.g., property maintenance, managing household chores, self-care, etc) (Billinger et al., 2014; Shariat et al., 2018; Timmermans et al., 2016). These functional limitations are often related to the hemiplegia that occurs as a result of the stroke (Kwakkel, Veerbeek, van Wegen, & Wolf, 2015). The levels of disability associated with stroke result in an enormous economic burden (Wang et al., 2014). Identifying strategies to maximize function and reduce the societal burden associated with stroke is of utmost importance.
In the first few weeks after a stroke, neurological deficits may improve as a result of brain plasticity. This brain plasticity may result from recruitment of different pathways, facilitation of existing but dormant synaptic junctions, aboritzation of dendrites and synaptogenesis (Rossini, Calautti, Pauri, & Baron, 2003). The magnitude of recovery differs greatly among individuals with similar clinical severity in the acute phase. The understanding of the mechanisms which prevent or promote recovery is critical to optimize therapeutic management strategies and maximize function. During treatment, sensory feedback and motor activity is essential (Rossini et al., 2003). Numerous studies have identified a relationship between afferent stimulation and changes in brain activity, such as repetition (Jones, 2000), efficient goal-directed activity (Nudo, Wise, SiFuentes, & Milliken, 1996), and functional electrical stimulation (FES) (Ambrosini, Ferrante, Pedrocchi, Ferrigno, & Molteni, 2011; de Sousa, Harvey, Dorsch, Leung, & Harris, 2016; Popović, Sinkjær, & Popović, 2009).
Outcomes after a stroke can potentially be enhanced through interventions focused on improving impairments, functional limitations and restrictions of participation (Billinger et al., 2014). One such intervention that may address these outcomes is cycling with/without electrical stimulation which has the potential to improve motor capacity and hypothetically result in greater participation and activity performance after a stroke (Barbosa, Santos, & Martins, 2015; Bauer, Krewer, Golaszewski, Koenig, & Müller, 2015). In comparison with conventional training modes, cycling is a low-cost and simple-to-use rehabilitation approach following a stroke (Mazzocchio, Meunier, Ferrante, Molteni, & Cohen, 2008).
Patients with a stroke who participate in daily cycle training have achieved major enhancements in their lower extremity (LE) muscle strength, balance ability, and aerobic capacity (Yang et al., 2014). Furthermore, participants who suffer from chronic stroke and participate in 10–12-weeks of cycling have been shown to experience improvements in cardiorespiratory fitness (Janssen et al., 2008). Even though multiple systems are affected by a stroke, such as motor control, balance, upper-extremity function, endurance, and gait, the majority of studies have only reported data on functional outcomes post stroke (Duncan et al., 2003). Most studies have used a simple form of cycling with/without FES (Bauer et al., 2015; de Sousa et al., 2016; M. Lee et al., 2008; S. Y. Lee et al., 2013; Yang et al., 2014). However, the optimal cycling protocol to maximize outcomes is not known for this population. An increasing number of physical therapists throughout the world are using cycling to treat lower limb dysfunction for patients post stroke (Billinger et al., 2014; Valles et al., 2016). As physical therapists use cycling more frequently, it is essential to continually evaluate the current evidence to refute or support its effectiveness. Therefore, the purpose of this systematic review and meta-analysis was to quantify the effectiveness of different protocols of cycling with/without FES on the lower limbs after stroke and to make recommendations for clinicians currently treating this population. The specific research question is as follow: Is cycling with FES more effective than cycling alone and if so, for which outcome measures?
Methodology
Protocol and registration
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed for this systematic review and meta-analysis (Moher, Liberati, Tetzlaff, Altman, & Group, 2009). This systematic review was registered a priori with PROSPERO on 03.01.2018 (CRD42017077974).
Figure 1 shows the criteria for inclusion of studies.

PRISMA flow chart.
The following criteria were used for the selection of relevant articles: Participants: Human subjects post-stroke (Adults ≥18 within 5 years after stroke). Intervention: Cycling with/without functional electrical stimulation (FES) to the lower limbs Comparison: cycling alone, cycling with FES, control, placebo, or other interventions Outcomes: Balance, walking speed, mobility Study design: Randomized clinical trial
Information sources
The following 7 electronic databases were searched till 2018; Pubmed, Cochrane Central Register of Controlled Trials, Ovid Medline, EBSCO Cumulative Index of Nursing and Allied Health Literature, Ovid EMBASE, Physiotherapy Evidence Database (PEDro) (www.pedro.org.au), and Occupational Therapy Systematic Evaluation of Effectiveness (www.otseeker.com) for relevant search terms including randomized, stroke, cycling, lower limb dysfunction using Boolean operators.
Search
In the databases of Cochrane Central Register of Controlled Trials, Medline, ISI Web of Science, EBSCO Cumulative Index to Nursing and Allied Health Literature, and Scopus. We searched our variables in terms of population such as cerebrovascular disorders, basal ganglia, cerebrovascular disease, brain ischemia, post-stroke, stroke, hemiplegia; intervention such as FES, muscle stimulation; study design such as randomized controlled trials, random allocation, controlled clinical trials, control groups, sham intervention, placebo, clinical trials, double-blinding, cross-over studies; outcomes such as gait, lower limb function, motor function, lower extremity, balance, postural control, mobility and walking.
AND was used to combine the search concepts of population, study design and outcome. OR was used with synonyms and similar terms. We used parentheses to help group parts of the search query, especially when we had several parts, and to set the order of the query for the database.
We searched for the subject heading first, then searched text words, combined these synonymous searches with OR using our search history. We repeated for the second, third and subsequent concepts. Finally we combined large search results set with AND.
Concept 1
Search #1
Search #2
Search # 3
Search #4 = #1 OR #2 OR #3
Concept 2
Search#5
Search#6
Search #7
Search#8 = #5 OR #6 OR #7
Search#9 = #4 AND #8
We also used filters, including date of publication (Till 2018), and design of study (only randomized control trials).
Study selection
Once duplicate studies were removed, 2 reviewers (AS and SN) independently screened the titles and abstracts to determine if studies potentially met eligibility for this systematic review and meta-analysis. If we identified studies that might be eligible or if we couldn’t determine if studies were eligible from the abstract a full text review was performed. Disagreements between reviewers were resolved by consulting a third reviewer (JC) who was blind to other reviewers’ decisions on whether the study should be included. Following the final study selection, we emailed the corresponding author on each of the selected studies and queried them regarding our list of studies and if they thought we might have missed potentially relevant studies for this systematic review. Where it was not possible to determine eligibility according to the information stated in the publication, the trial’s authors were contacted to determine missing information. If multiple studies reported the same data only the article with the longest follow-period was included in the systematic review and meta-analysis.
Data collection process
Data extraction was performed by the primary investigator (AS), and was compiled into a standardized form (Gattie, Cleland, & Snodgrass, 2017; Howlett, Lannin, Ada, & McKinstry, 2015). Data included sample size, diagnosis, inclusion/exclusion criteria, duration of symptoms, type of cycling intervention (location, technique, and duration), main outcomes, time to outcome, and harm reported. Included studies were analyzed for methodological quality by 2 independent reviewers (AS and SN), based on risk of bias table in the Cochrane handbook. Disagreements between the reviewers were again settled by a 3rd reviewer (JC) who was blind to previous assessment scores.
Data items
Our variables were based on PICO:
Population: stroke, cerebrovascular, cerebrovascular disorder, hemiparesis, hemiplegia.
Intervention: cycling, leg ergometer, functional electrical stimulation, bike training, functional stimulation, lower limb exercise.
Comparison: control, experimental, sham, conventional therapy, standard therapy.
Outcome: balance, walking speed, mobility.
Risk of bias in individual studies
Random sequence generation (selection bias), Allocation concealment (selection bias), Blinding of participants and personnel (performance bias) all study design outcomes, Blinding of outcome assessment (detection bias all outcomes), Incomplete outcome data (attrition bias) all outcomes, and Selective reporting (reporting bias(were determined using the Cochrane risk of bias that has three level of bias (low risk of bias, high risk of bias, or unclear risk of bias).
Synthesis of results
Kappa statistics provided an estimate of inter-rater agreement. RevMan (The Nordic Cochrane Centre, Copenhagen, Denmark) was used to perform meta-analyses (Landis & Koch, 1977). Outcome measures used different scales of measurement with 95% CIs were used to investigate differences (Takeshima et al., 2014). Study variability and heterogeneity was tested by a fixed effects model and the I2 statistic (Higgins & Green, 2011). The I2 value of 25% represents a small, 50% a moderate, and 75% a large degree of heterogeneity (Higgins, Thompson, Deeks, & Altman, 2003). Based on previous research, we described 0.2 as small, 0.5 as moderate, and 0.8 as large effect sizes (Cohn, 1988). As we had fewer than 10 studies for each comparison we did not develop the funnel plot as it has been suggested that power would be artificially inflated (Sterne et al., 2011).
Using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach (Balshem et al., 2011) two reviewers (AS and JC) analyzed each study separately. Once the reviewers appraised the evidence, the quality was categorized on a level of evidence using the following criteria (Guyatt et al., n.d.): High-quality evidence: Additional research would not be likely to change our confidence in the estimate of effect Moderate-quality evidence: Additional research is likely to show a significant influence on our confidence in the evaluation of effect and may change the evaluation Low-quality evidence: Additional research is to be expected to show a significant effect on our confidence in the estimate of effect and can probably change the estimate Very low–quality evidence: Any effect estimate is very indeterminate.
Randomized clinical trials were scored as high-quality evidence but were downgraded based on the following 5 items: (1) research design and risk of bias (reduced if more than 25% of the participants were from studies used risk of bias table in Cochrane handbook; (2) represented heterogeneity (reduced if significant heterogeneity existed on visual inspection or the I2 value was more than 50%); (3) Reduced generalizability(downgraded if more than 50% of the participants were outside the target group); (4) imprecision (reduced if fewer than 40 participants were included in the comparison for continuous data); and (5) other (publication bias) (Saragiotto et al., 2016).
Results
Study selection
Citations for 2084 trials were identified in the original search. After duplicates were removed, 1845 records remained and were screened. Of these, 1718 were excluded after screening based on the title and abstract. 127 Articles were assessed for full text eligibility. Of these, 113 trials were excluded after full-text review, leaving 14 trials for inclusion. See Fig. 1 for a summary of the flow of trials through the review.
Study characteristics
The 14 trials included in the review included 794 participants who were assigned for randomization and 680 participants who completed the final follow-up. Across the trials, the mean age ranged from 42.5 to 85 years, and 60% of participants were men. All trials included only participants who had suffered a stroke. The mean time after stroke ranged from >1 to 27 months, with 70% of the trials carried out on patients who had a stroke greater than 3 months prior to enrollment. Details about the characteristics of participants have been reported in Table 1.
Summary of included trials
Summary of included trials
Con = control group; Exp = experimental group; RCT = randomised clinical/control trial; F = female; M = male; n = number; mo = month; yr = year.
We included studies that examined FES on the function of the lower limb. Frequency of the interventions ranged from 1 to 7 sessions per week (for studies with cycling from 3–7 sessions) and (for studies with from 1–6 sessions) while the length of each session was from 10 to 90 minutes (for studies with cycling from 6 min–90 min) and (for studies with cycling from 17–30 min). The duration of interventions ranged from 3 to 16 weeks (for cycling alone 3–72 weeks and for cycling with FES about 4 weeks), with the total dose of the stimulation between 4 and 16 hours. Parameters of electrical stimulation varied across studies as the frequency ranged from 20 to 60 Hz and pulse width from 300 to 450 ms. Electrical stimulation was provided by the therapist or the participant, either mechanically (e.g., by aid of a foot switch) or physiologically (e.g., by setting a threshold for muscle activity). Participants performed several movements such as ankle dorsiflexion during the stimulation. Finally, for the control intervention, 10 studies used sham stimulation but in 4 studies, control participants received no stimulation.
Results showed that lower limb function was assessed using 2-, 6-, 10-, or 50-meter walking, Timed “Up&Go”-Test (TUG), Berg Balance Scale (BBS), Postural Assessment Scale for Stroke Patients (PASS), Barthel Index (BI), Functional Mobility Scale (FMS), Tinetti-test, Dynamometer, the Stair Climbing Test, the leg subscale of the Motricity Index, Trunk Control Test (TCT), Upright Motor Control Test (UMCT), Functional Ambulation Classification (FAC), or Performance-oriented Mobility Assessment (POMA) in 13 studies. The Modified Ashworth Scale (MAS), FMS, Dynamometer, Wolf Motor Function, or Hoffmans reflex were used for upper limb function in 6 studies. Furthermore, physiological parameters were assessed in five trials using peak aerobic capacity, physiological cost index, VO2 max, metabolic equivalent (MET), Exercise tolerance test, or not and Short-Form Health Survey RAND-36. In only one study did no participants experience side effects after an intervention (Sullivan et al., 2007). There were 17 adverse events during the intervention period, 8 of which were not study-related (4 falls in home, 1 report of low back pain, 1 controlled seizure, 1 participant diagnosed with colon cancer, 1 participant diagnosed with congestive heart failure after randomization but prior to starting the intervention) (Sullivan et al., 2007).
Study-related events included: (1) in the BWSTT/UE-EX group, minor hand abrasion and foot pain; (2) in the BWSTT/CYCLE group, foot pain, reduced blood pressure, and increased blood pressure (twice in 1 participant); and (3) in the BWSTT/ LE-EX group, gluteus medius muscle pain and toe pain, with a later diagnosis of toe stress fracture (2 occurrences in 1 participant). Four participants were withdrawn from the study by the administration due to the adverse events. Two adverse events were considered related to the study (foot pain, toe stress fracture), and 2 adverse events were considered not related to the study but due to cardiac conditions (congestive heart failure, high blood pressure not responsive to medication). The participant with colon cancer withdrew from the study.
Data on risk of bias of each study are presented in Table 2.
Cochrane Table of Risk of Bias
Cochrane Table of Risk of Bias
Cycling vs. control on walking speed
The effect of cycling on walking speed was examined by pooling data after the intervention from 6 trials consisting of 249 participants. Cycling improved walking speed compared to control (SMD, 0.30; 95% CI, 0.05 –0.55; I2 = 0% ). Five trials used 10 MWK test and one trial (Olney et al., 2006) used 6 MWK test as an outcome measurement. The overall results showed that cycling had a positive and significant effect on walking speed in comparison with control (P < 0.02) (Fig. 2).

Standardized mean difference (95% CI) of walking speed after cycling as compared with a control from five studies. Sensitivity analysis showed that walking speed was significant except by excluding one trial at a time from pooled effects to determine whether any one study was particularly influential. Susceptibility analysis showed there is stability results for this meta-analysis.
The effect of cycline vs. no training was examined by pooling data after intervention from 5 trials consisting of 177 participants. Cycling improved walking ability compared with control (SMD, 0.41; 95% CI, 0.11 –0.71; I2 = 0%). The analysis included 4 trials of walking ability measured by the 6 MW test and one trial (Kim, Cho, Kim, & Lee, 2015) used 10 MWK test as outcome measurements. The analysis included 4 RCTs and one cross-over study (measure of T2 after the first period intervention and control) of walking speed that measured 6 MW test. The overall results showed that cycling had a positive effect on walking ability in comparison to a control group, and this effect was significant (P < 0.007) (Fig. 3).

Standardized mean difference (95% CI) of walking ability after cycling as compared with a control from four studies. Sensitivity analysis showed that walking ability was significant by excluding one trial at a time from pooled effects to determine whether any study was particularly influential. Susceptibility analysis showed by excluding studies with <20 subjects there was stability of results for this meta-analysis.
The effect of cycling vs. a control group was examined by pooling data after intervention from 5 trials consisting of 251 participants. Cycling improved balance compared with a control (SMD, 0.32; 95% CI, 0.06 –0.57; I2 = 49%). The analysis included 4 trials of balance that were measured using the Berg Balance Scale but one trial (Katz-Leurer, Sender, Keren, & Dvir, 2006) measured balance using the postural assessment scale for patients post-stroke (PASS). The overall results showed that cycling had a significant effect on balance in comparison with control (P < 0.01) (Fig. 4).

Standardized mean difference (95% CI) of balance after cycling as compared with a control from five studies. Sensitivity analysis showed that Balance was significant except by excluding one trial at a time from pooled effects to determine whether any one study was particularly influential. Susceptibility analysis showed by excluding studies with <20 subjects there was stability of results for this meta-analysis.
The effect of cycling with FES vs. a control group was examined by pooling data from 2 trials consisting of 96 participants (Bauer et al., 2015; S. Y. Lee et al., 2013). Cycling with FES improved balance compared with a control group (SMD, 1.48; 95% CI, 0.99 –1.97; I2 = 91%). The analysis included one trial of balance that was measured using the Berg Balance Scale but one trial (Bauer et al., 2015) used the Functional ambulation classification (FAC) and performance-oriented mobility assessment (POMA). The overall results indicated that cycling with FES had a significant and positive effect on balance (P < 0.00001) (Fig. 5).

Standardized mean (95% CI) of balance after cycling with FES as compared with a control from two studies. Sensitivity analysis showed that balance was significant by excluding one trial at a time from pooled effects to determine whether any one study was particularly influential. Suceptability analysis showed by excluding studies with <20 subjects there was stability of results for this meta-analysis.
Summary of main results
We completed a systematic review and meta-analysis examining the effects of cycling with/without FES on the lower limbs in survivors post stroke compared to control groups. We identified 14 randomized controlled trials (479 participants) investigating this clinical question. In this review participants’ age range was from 42.5 to 85 years. The mean time after stroke ranged from > 1 to 27 months. The duration of interventions ranged from 3 to 16 weeks (for cycling alone 3–72 weeks and for cycling with FES about 4 weeks), with the total dose of the stimulation between 4 and 16 hours. Parameters of electrical stimulation varied across studies as the frequency ranged from 20 to 60 Hz and pulse width from 300 to 450 ms.
However, because of a lack of sufficient data, we could not examine the effects of this on lower limb function and balance in the long-term. We cannot suggest the most effective protocol of cycling with/without FES for patients post stroke with lower limb disability because of the inconsistency of previous trial methods.
Our results showed that cycling had a positive effect on the walking ability (SMD, 0.41; 95% CI, 0.11 –0.71; I2 = 0%; P < 0.007) compared with no or placebo intervention (control). Compared with control, cycling had a positive effect on walking speed (SMD, 0.30; 95% CI, 0.05 –0.55; I2 = 0%; P < 0.02), and on balance based on the Berg score (SMD, 0.32; 95% CI, 0.06 –0.57; I2 = 49%; P < 0.01). Concurrent use of cycling with functional electrical stimulation had a positive effect on balance compared with control? (SMD, 1.48; 95% CI, 0.99 –1.97; I2 = 91%; P < 0.00001) and compared with cycling alone, the effect was higher.
Limitations
There were some limitations to the literature upon which this systematic review was based. First, we included all applicable studies, however many of them included small sample sizes which may limit their generalizability. Additionally, we only included English language literature. Third, studies used different measures of function and disability which required us to report combined outcomes as the standardized mean difference which is difficult for clinicians to translate to actual practice. Fourth, no systematic searching was done for unpublished literature. Fifth, primary and secondary outcomes were not defined clearly in all the studies.
Agreements and disagreements with other studies or reviews
In a previous systematic review with meta-analysis (Howlett et al., 2015). Howlett et al. have examined the effects of FES on physical activity of patients post stroke generally focusing on lower-limb or upper-limb function. The results showed that FES had a small to moderate positive effect on activity compared with no or placebo intervention. The results suggested that FES was more beneficial than training alone with a moderate effect size. These authors used lower limb outcomes mostly focused on walking speed. Balance, which is important in functional ability of the lower limb, was not assessed. Additionally, they did not examine the effects of cycling combined with FES, so it was not possible to predict if cycling with FES is more effective for balance compared with cycling or FES alone.
In a meta-analysis, Robbins et al. reported that FES resulted in significant positive effects on increasing walking speed compared to walking training alone or no intervention in patients post stroke, based on the results of three controlled trials in patients chronic post stroke (Robbins, Houghton, Woodbury, & Brown, 2006). However the effects on balance, other determinants of functional ability of lower extremity were not evaluated. Pereira et al. in 2012 reported that FES improved walking distance in the 6-min walk test with a small but significant treatment effect, based on six controlled trials but walking ability and balance were not assessed (Pereira, Mehta, McIntyre, Lobo, & Teasell, 2012).
Conclusion
Implications for practice
Rehabilitation may offer additional benefit. However, the very limited literature suggests that more studies are needed comparing FES cycling directly with other modalities of exercise such as balance training, strength training, power training or combinations, to determine its relative efficacy. In addition, the additional cost and lack of generalizability of FES cycling to home or non-specialized rehabilitation services is an important issue that needs to be considered.
Implications for research
Cycling is superior to control for improving walking speed, walking ability, and balance. Cycling with FES has a significant and positive effect on balance compared to cycling without FES. Although more research is needed, patients post stroke with lower limb disability could use cycling with FES as part of their rehabilitation program. In order to determine the ideal protocol of prescribing cycling with FES as a part of post stroke more research is needed and future research should including clinically meaningful outcomes related to functional mobility such as falls and fall-related injuries and other co-morbidities related to higher physical activity levels and community ambulation.
Conflict of interest
The author(s) declared no potential conflicts of interests with respect to the research, authorship, and/or publication of this article.
Funding
This study was supported by Sports Medicine Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran (IR.TUMS.VCR.REC.1396.4226).
Footnotes
Acknowledgments
Our special thanks go to Prof. Ramin Kordi, Sports Medicine Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran, for his support.
